A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection

Journal of General Virology

Volumn 88, Issue 1, 2007, Pages 217-225

  Breton, Marie ^a   Zhao, Chenqi ^a   Ouellette, Marc ^a   Tremblay, Michel J ^a   Papadopoulou, Barbara ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; GAMMA INTERFERON; LEISHMANIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; EX VIVO STUDY; EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNIZATION; LEISHMANIA TARENTOLAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TISSUE CULTURE; TONSIL; VIRUS REPLICATION;

AIDS VACCINES; ANIMALS; ANTIBODY SPECIFICITY; GENE PRODUCTS, GAG; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; LEISHMANIA; MICE; MICE, INBRED BALB C; VACCINES, SYNTHETIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LEISHMANIA TARENTOLAE; MUS; PROTOZOA;

EID: 33846155868     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81995-0     Document Type: Article

References (43)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A. & Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59, 284-291.
2. Amara, R. R., Villinger, F., Altman, J. D., Lydy, S. L., O'Neil, S. P., Staprans, S. I., Montefiori, D. C., Xu, Y., Herndon, J. G. & other authors (2001). Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292, 69-74.
3. Andersson, E. C., Christensen, J. P., Marker, O. & Thomsen, A. R. (1994). Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J Immunol 152, 1237-1245.
4. Baba, T. W., Jeong, Y. S., Pennick, D., Bronson, R., Greene, M. F. & Ruprecht, R. M. (1995). Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825.
5. Barouch, D. H., Santra, S., Kuroda, M. J., Schmitz, J. E., Plishka, R., Buckler-White, A., Gaitan, A. E., Zin, R., Nam, J.-H. & other authors (2001). Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. J Virol 75, 5151-5158.
6. Barouch, D. H., McKay, P. F., Sumida, S. M., Santra, S., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Chakrabarti, B. K., Xu, L. & other authors (2003). Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. J Virol 77, 8729-8735.
7. + T-cell responses: relationship to viral load in untreated HIV infection. J Virol 75, 11983-11991.
8. + -T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J Virol 76, 1004-1014.
9. Breton, M., Tremblay, M. J., Ouellette, M. & Papadopoulou, B. (2005). Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis. Infect Immun 73, 6372-6382.
10. Brun, R. & Schönenberger, M. (1979). Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Acta Trop 36, 289-292.
11. Clayton, C. E. (2002). Life without transcriptional control? From fly to man and back again. EMBO J 21, 1881-1888.
12. DeGrendele, H. C., Estess, P. & Siegelman, M. H. (1997). Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278, 672-675.
13. Donnelly, J. J., Wahren, B. & Liu, M. A. (2005). DNA vaccines: progress and challenges. J Immunol 175, 633-639.
14. Gilbert, P. B., Peterson, M. L., Follmann, D., Hudgens, M. G., Francis, D. P., Gurwith, M., Heyward, W. L., Jobes, D. V., Popovic, V. & other authors (2005). Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis 191, 666-677.
15. Glushakova, S., Baibakov, B., Margolis, L. B. & Zimmerberg, J. (1995). Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat Med 1, 1320-1322.
16. Goulder, P. J. R., Altfeld, M. A., Rosenberg, E. S., Nguyen, T., Tang, Y., Eldridge, R. L., Addo, M. M., He, S., Mukherjee, J. S. & other authors (2001). Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 193, 181-194.
17. Granucci, F., Feau, S., Zanoni, I., Pavelka, N., Vizzardelli, C., Raimondi, G. & Ricciardi-Castagnoli, P. (2003). The immune response is initiated by dendritic cells via interaction with microorganisms and interleukin-2 production. J Infect Dis 187 (Suppl. 2), S346-S350.
18. + T lymphocytes survive in HIV-infected human lymphoid tissue. AIDS Res Hum Retroviruses 19, 211-216.
19. Harrer, T., Harrer, E., Kalams, S. A., Elbeik, T., Staprans, S. I., Feinberg, M. B., Cao, Y., Ho, D. D., Yilma, T. & other authors (1996). Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruscs 12, 585-592.
20. Horton, H., Vogel, T. U., Carter, D. K., Vielhuber, K., Fuller, D. H., Shipley, T., Fuller, J. T., Kunstman, K. J., Sutter, G. & other authors (2002). Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J Virol 76, 7187-7202.
21. - T lymphocytes. Nature 421, 852-856.
22. + T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189, 991-998.
23. Klenerman, P. & Hill, A. (2005). T cells and viral persistence: lessons from diverse infections. Nat Immunol 6, 873-879.
24. Letvin, N. L. (2005). Progress toward an HIV vaccine. Annu Rev Med 56, 213-223.
25. Letvin, N. L., Barouch, D. H. & Montefiori, D. C. (2002). Prospects for vaccine protection against HIV-1 infection and AIDS. Annu Rev Immunol 20, 73-99.
26. MacGregor, R. R., Boyer, J. D., Ugen, K. E., Lacy, K. E., Gluckman, S. J., Bagarazzi, M. L., Chattergoon, M. A., Baine, Y., Higgins, T. J. & other authors (1998). First human trial of a DNA-based vaccine for treatment of human immunodeficiency Virus type 1 infection: safety and host response. J Infect Dis 178, 92-100.
27. Margolis, L. B., Fitzgerald, W., Glushakova, S., Hatfill, S., Amichay, N., Baibakov, B. & Zimmerberg, J. (1997). Lymphocyte trafficking and HIV infection of human lymphoid tissue in a rotating wall vessel bioreactor. AIDS Res Hum Retroviruses 13, 1411-1420.
28. Mashishi, T. & Gray, C. M. (2002). The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes. Clin Chem Lab Med 40, 903-910.
29. McConkey, S. J., Reece, W. H. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., Vuola, J. M., Blanchard, T. J., Gothard, P. & other authors (2003). Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 9, 729-735.
30. McMichael, A. J. & Hanke, T. (2003). HIV vaccines 1983-2003. Nat Med 9, 874-880.
31. Melief, C. J. M. (2003). Mini-review: regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming? Eur J Immunol 33, 2645-2654.
32. Moore, J. P., Trkola, A., Korber, B., Boots, L. J., Kessler, J. A., II, McCutchan, F. E., Mascola, J., Ho, D. D., Robinson, J. & Conley, A. J. (1995). A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B. J Virol 69, 122-130.
33. Murphey-Corb, M., Martin, L. N., Davison-Fairburn, B., Montelaro, R. C., Miller, M., West, M., Ohkawa, S., Baskin, G. B., Zhang, J. Y. & other authors (1989). A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297.
34. Norton, J. D. (1997). Technical tips online. Simple and efficient panning of transfected cell populations expressing a cell surface marker. Trends Genet 13, 41.
35. Papadopoulou, B., Roy, G. & Ouellette, M. (1992). A novel antifolate resistance gene on the amplified H circle of Leishmania. EMBO J 11, 3601-3608.
36. Redfield, R. R., Wright, D. C., James, W. D., Jones, T. S., Brown, C. & Burke, D. S. (1987). Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 316, 673-676.
37. + lymphocytes. Science 283, 857-860.
38. Seaman, M. S., Peyerl, F. W., Jackson, S. S., Lifton, M. A., Gorgone, D. A., Schmitz, J. E. & Letvin, N. L. (2004). Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo. J Viral 78, 206-215.
39. Seth, A., Ourmanov, I., Schmitz, J. E., Kuroda, M. J., Lifton, M. A., Nickerson, C. E., Wyatt, L., Carroll, M., Moss, B. & other authors (2000). Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge. J Virol 74, 2502-2509.
40. Shedlock, D. J. & Shen, H. (2003). Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337-339.
41. Whitney, J. B. & Ruprecht, R. M. (2004). Live attenuated HIV vaccines: pitfalls and prospects. Curr Opin Infect Dis 17, 17-26.
42. Yan, S., Lodes, M. J., Fox, M., Myler, P. J. & Stuart, K. (1999). Characterization of the Leishmania donovani ribosomal RNA promoter. Mol Biochein Parasitol 103, 197-210.
43. Zhao, C., Papadopoulou, B. & Tremblay, M. J. (2004). Leishmania infantum promotes replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing secretion of the proinflammatory cytokines TNF-α and IL-1α. J Inimunol 172, 3086-3093.